L362-1410 Screening compound: methyl 3-[({3-[2-(1-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}carbamoyl)amino]benzoate

L362-1410 Screening compound: methyl 3-[({3-[2-(1-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}carbamoyl)amino]benzoate
L362-1410 Screening compound: methyl 3-[({3-[2-(1-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}carbamoyl)amino]benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound L362-1410
methyl 3-[({3-[2-(1-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}carbamoyl)amino]benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L362-1410

Molecular Formula

C25H24N4O3 (C25 H24 N4 O3)

Compound Name

methyl 3-[({3-[2-(1-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}carbamoyl)amino]benzoate

IUPAC name

methyl 3-[({3-[2-(1-methyl-1H-13-benzodiazol-2-yl)ethyl]phenyl}carbamoyl)amino]benzoate

SMILES

Cn1c(cccc2)c2nc1CCc1cccc(NC(Nc2cc(C(OC)=O)ccc2)=O)c1

InChI

InChI=1S/C25H24N4O3/c1-29-22-12-4-3-11-21(22)28-23(29)14-13-17-7-5-9-19(15-17)26-25(31)27-20-10-6-8-18(16-20)24(30)32-2/h3-12,15-16H,13-14H2,1-2H3,(H2,26,27,31)

InChI Key

RTFMKARMSIIRBC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15124970

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.49

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.516

Distribution Coefficient, logD

5.391

Water Solubility, LogSw

-5.46

Polar Surface Area

65.430

Acid Dissociation Constant (pKa)

13.72

Base Dissociation Constant (pKb)

6.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.00

L362-1410 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

SH2 Library (10483 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cancer
  • Endocrine
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Epigenetic
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with L362-1410 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L362-1410?
Check Price and Availability of L362-1410, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L362-1410 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L362-1410
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L362-1410
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L362-1410 available by request